Actively Recruiting
Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
Led by Hospices Civils de Lyon · Updated on 2025-04-04
75
Participants Needed
1
Research Sites
255 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.
CONDITIONS
Official Title
Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with one or more small-intestine neuroendocrine tumor with indication of surgery
- Patient with consent for the collection, storage and reuse of data associated with his/her disease
- Age ≥ 18 years at the time of inclusion
- Non-objection statement obtained for participation in the study
You will not qualify if you...
- Patients with poorly differentiated neuroendocrine carcinoma or NET (neuroendocrine tumors) of non-intestinal origin or mixed tumors (MiNEN)
- Pregnant, parturient or breast-feeding women
- Minors
- Persons deprived of liberty by judicial or administrative decision
- Adults under legal protection (guardianship, curatorship)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Edouard Herriot University Hospital
Lyon, France, France, 69003
Actively Recruiting
Research Team
T
Thomas WALTER, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here